| FULL STACK DEVELOPER 100% remote ( with pharmaceutical background.) NO H1B or CPT at Remote, Remote, USA |
| Email: [email protected] |
|
I have a new role with Pfizer Pharmaceutical company. This one is for a 100% remote FULL STACK DEVELOPER. The candidate MUST have strong pharma experience with pharmaceutical background. ALL CANDIDATES MUST BE SENT WITH VALID LINKEDIN PROFILES. THEY WILL BE SCREENED BY ME EXSISTENSIVELY. I will not submit anyone that does not have this. Please review the job description and let me know if you have any questions! Role summary: Our client, a leader in drug discovery and development, is seeking a skilled Full Stack developer to join their Computational Toxicology Team within the Drug Safety Research and Development Department. This is an exciting opportunity to design and implement a set of coding best practices for the computational safety sciences group within Drug Safety Research and Development. Role responsibilities Develop best practices for code to increase maintainability and performance. Improve code to be more maintainable and performant. Identify opportunities to consolidate redundant code. Setup and manage compute environments. Required skills and experience Bachelors degree and significant development experience Strong coding skills (R and python preferred). Experience using git and GitHub. Comfortable setting up compute environments (pyenv, poetry, renv). Ability to work in a collaborative environment on shared coding challenges. Additional skills Experience in R and python package development including testing and documentation. Comfortable communicating with databases (MariaDB, PostgreSQL) from R and python. Web application development (R Shiny, Streamlit, Jupyter Notebooks), particularly with Posit Connect. Thanks & Regards, ADARSH PATERIYA Technical Recruiter Office: +1 (703) 570-8775 Ext No-(231) Email- [email protected] Keywords: rlang FULL STACK DEVELOPER 100% remote ( with pharmaceutical background.) NO H1B or CPT [email protected] |
| [email protected] View All |
| 07:55 PM 25-Nov-24 |